Selected loss of tolerance evidenced by Crohn's disease–associated immune responses to auto- and microbial antigens
- 1 September 2002
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 123 (3) , 689-699
- https://doi.org/10.1053/gast.2002.35379
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosisGut, 2001
- The Crohn's disease lesion derived gene, 12, encodes the core paptide of a transcriptional regulator of Pseudomonas fluorescens, and the functional domain of a novel T cell superantigenGastroenterology, 2001
- Selected, not global, loss of tolerance using Crohn's disease (CD)-associated immune responses to auto-and specific bacterial antigensGastroenterology, 2001
- IL-10 deficient mice monoassociated with non-pathogenic Enterococcus faecalis develop chronic colitisGastroenterology, 2001
- IGA serum antibody reactivity with I2, a novel Crohn's disease marker: anti-I2 level is independent from ASCA and ANCA levels, even though IGA ASCA positivity is correlated with anti-I2 positivityGastroenterology, 2000
- Identification of Histone H1 as a Cognate Antigen of the Ulcerative Colitis-associated Marker Antibody pANCAJournal of Autoimmunity, 2000
- Mast Cell and Neuroendocrine Cytoplasmic Autoantigen(s) Detected by Monoclonal pANCA AntibodiesClinical Immunology, 2000
- High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitisGastroenterology, 1995
- Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileumThe Lancet, 1991
- BiometryPublished by JSTOR ,1982